Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Fondaparinux may help prevent blood clots from forming in patients who are
undergoing surgery for gynecologic cancer.
PURPOSE: This phase II trial is studying how well fondaparinux works in preventing blood
clots in patients undergoing surgery for gynecologic cancer.